Summary
The value of two-dimensional strain echocardiography for assessing left ventricular regional systolic function in breast cancer patients who were treated with epirubicin was evaluated. A total of 116 breast cancer patients were divided into 3 groups: Thirty-eight patients in group A were given epirubicin (Epi) of 120–340 mg/m2, 42 patients in group B received epirubicin of ≥ 360 mg/m2, and 36 patients after surging without chemotherapy served as the control group C. High frame rate two-dimensional images were recorded from apical long-axis view, four-chamber view, two-chamber view of left ventricle. Peak systolic strain of left ventricular subendocardial myocardium was measured using two-dimensional strain software. The conventional echocardiographic parameters were also obtained. Conventional echocardiography showed there was no significant changes in conventional echocardiographic parameters among the three groups (P>0.05). Two-dimensional strain echocardiography revealed that the peak systolic strain of left ventricular subendocardial myocardium in group A was reduced in some segments as compared with the controls (P<0.05). The peak systolic strain of left ventricular subendocardial myocardium in group B was reduced significantly as compared with group C (P<0.05), but that was reduced in group B just in some of the segments as compared with group A (P<0.05). It was concluded that two-dimensional strain echocardiography could early and sensitively display the effects of epirubicin-induced cardiotoxicity on the systolic function of left ventricular subendocardial myocardium, and early monitor the epirubicin-induced cardiotoxicity.
Similar content being viewed by others
References
Altman DG. Prognostic models: a methodological framework and review of models for breast cancer. Cancer Invest, 2009,27(3):235–243
Kremer LC, Vam-Dalen EC, Offringa M, et al. Anthracycaline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol, 2001, 19(1):191–196
Lenihan DJ, Esteva FJ. Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancer. Oncologist, 2008, 13(12):1224–1234
Hrdina R, Gersl V, Klimtova I, et al. Anthracycline-induced cardiotoxicity. Acta Medica (HradecKralove), 2000,43(3):75–82
Suzuki J, Yanagisawa A, Shiqeyama T, et al. Early detection of anthracycline-induced cartdiotoxicity by radionuclide angiocardiography by radionuclide angiocardiography. Angiology, 1999,50(1):37–45
Gennari A, Pronzato P. New understanding of the role of anthracyclines in early-stage breast cancer: patient selection considerations. Clin Breast Cancer, 2008,8(Suppl 4):S179–S183
Di Leo A, Moretti E. Anthracyclines: the first generation of cytotoxic targeted agents? A possible dream. J Clin Oncol, 2008,26(31):5011–5013
Radulescu D, Pripon S, Radulescu LI, et al. Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines. Acta Cardiol, 2008, 63(1):27–32
Ryberg M, Nielsen D, Cortese G, et al. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. J Natl Cancer Inst, 2008, 100(15):1058–1067
Zekri JM, El-Helw LM, Purohit OP, et al. Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function. Clin Oncol (R Coll Radiol), 2008,20(7):513–516
Adams MJ, Lipshultz SE. Pathophysiology of anthracycline and radiation associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer, 2005,44(7):600–606
Singal PK, Lliskovic N. Doxorubicin—induced Cardiomyopathy. N Engl J Med, 1998,339(13): 900–905
Ichinose I, Hamada Y, Mitsuyama S, et al. Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer. Chemotherapy, 2008, 54(5):379–85
Hershman DL, Neugut AI. Anthracycline cardiotoxicity: one size does not fit all! J Natl Cancer Inst, 2008,100(15):1046–1047
Pan XF, Wang K, Zhao XL, et al. Clinical significance of investigating myocardial transmural heterogeneity by integrated backscatter in patients with chronic ischemic dysfunctional myocardium. Chin J Ultras Med (Chinese), 2005,21(3):175–179
Mortensen SA, Olsen HS, Baandrup U. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestation suggesting a restrictive endomyocardial disease. Br Heart J, 1986,55(3):274–282
Jurcut R, Wildiers H, Ganame J, et al. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr, 2008,21(12): 1283–1289
Hashimoto I, Li X, Hejmadi Bhat A, et al. Myocardial strain rate is a superior method for evaluation of left ventricular subendoca—radial function compared with tissue Doppler imaging. J Am Coll Cardiol, 2003,42(9): 1574–1583
Sutherland GR, Di Salvo G, Claus P, et al. Strain and strain rate imaging: a new clinclical approach to quantifying regional myocardial function. J Am Soc Echocardiogr, 2004,17(7):788–802
Bi XJ, Deng YB, Shentu WH, et al. Assessment of left ventricular dyssynchrony in patients with hypertrophic cardiomyopathy by two-dimensional strain echocardiography. Chin J Med Imaging Technol (Chinese), 2008, 24(11):1763–1766
Tong C, Li CL, Song JL, et al. Assessment of right ventricular free wall longitudinal myocardial deformation using speckle tracking imaging in normal subjects. J Huazhong Univ Sci Technol: Med Health (Chinese), 2008,28(2):194–196
Oberholzer K, Kunz RP, Dittrich M, et al. Anthracycline-induced Cardiotoxicity: Cardiac MRI after treatment for childhood cancer. Rofo, 2004,176(9):1245–1250
Onose Y, Oki T, Mishiro Y, et al. Influence of aging on systolic left ventricular wall motion velocities along the long and short axis in clinically normal patients determined by pulse tissue Doppler imaging. J Am Soc Echocardiogr, 1999,12(11):921–926
Langeland S, D’hooge J, Wouters PF, et al. Experimental validation of a new ultrasound method for the simultaneous assessment of radial and longitudinal myocardial deformation independent of insonation angle. Circulation, 2005,112:2157–2162
Jiang ZR, Lv HX, Liu PJ, et al. Echocardiography in assessment of cardiotoxity in breast cancer patients treated with anthracycline. Chin J Med Imaging Technol (Chinese), 2005,21(8):1209–1212
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bi, X., Deng, Y., Zeng, F. et al. Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 391–394 (2009). https://doi.org/10.1007/s11596-009-0326-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-009-0326-7